FDA Inspection 1233220 — Colgate-Palmolive Company
The FDA completed an inspection of Colgate-Palmolive Company on Feb 16, 2024 in Piscataway, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 16, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Piscataway, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)